Objective: This study was carried out to determine the prevalence of hepatitis B virus (HBV) markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Materials and methods: A cross-sectional survey was done among male Saudi voluntary blood donors at the blood bank of the King Khalid tertiary care hospital in the northwest region of Saudi Arabia. A total of 3192 subjects were included in the study over the period from June 1, 2005 to May 31, 2006. Subjects were tested for evidence of HBV infection plus other relevant blood-borne pathogens. A questionnaire sheet for the collection of personal information (such as name, age, and sex), socioeconomic data (such as marital status, education, and occupation), family history of HBV infection, history of immunization against HBV, and history of past exposure to a high risk procedure or behavior, was prepared and used for each subject. Data were tabulated and statistically analyzed. Results: Among the studied sample, the prevalence of HBsAg (hepatitis B surface antigen) was found to be 3.0% and the prevalence of anti-HBc (anti-hepatitis B core antigen) was found to be 18.7%. Blood donors with positive HBV markers showed significant association with increased age, being married, lower educational level, specific occupations such as blue collar worker and the military, family history of HBV infection, and lack of immunization. However, there was no significant association with history of exposure to high-risk procedure or behavior. Conclusions: The prevalence of HBV infection among male Saudi blood donors in the northwest region of Saudi Arabia is high compared to that reported from the central capital area (Riyadh). Public health education programs on HBV infection, adult hepatitis B immunization programs, and raising socioeconomic standards should be initiated in order to target the high-risk groups found in this study. Furthermore, a community-based study is recommended to investigate HBV infection in the northwest region of Saudi Arabia. #
Introduction
Hepatitis B virus (HBV) infection is a major health problem in many countries of the world, especially those in Asia, the Middle East, and Africa. 1 It is a major cause of chronic liver diseases, particularly cirrhosis and hepatocellular carcinoma. Although the incidence of HBV infection has markedly reduced following mass HB vaccination programs, the average prevalence of chronic HBV infection worldwide is still estimated at 6.6% (2.8% in developed countries and 7.6% in developing countries). 2 It was predicted that there would be at least 400 million cases of HBV chronic infection worldwide in the year 2000, and the figure has now risen beyond this limit. HBV infection has an acute case fatality rate of 0.5-1.0%, while 2-10% of cases end up in chronic infection after 5 years. Premature mortality from chronic liver disease occurs in 15-25% of chronically infected persons, highlighting the importance of this global health concern. 3 In recent years, there has been increased public concern regarding the safety of blood and blood products with respect to transfusion-transmitted infections, mainly HBV, hepatitis C virus (HCV), and human immunodeficiency virus (HIV). 4 In the Kingdom of Saudi Arabia, the average prevalence rate of HBsAg (hepatitis B surface antigen) in the adult population in 1988 was approximately 8%, while 60% had evidence of past exposure to HBV. 5, 6 Also, a high prevalence of HBV infection among children was reported in 1992; approximately 7% of apparently healthy children less than 10 years of age were positive for HBsAg and 20% were positive for at least one of the markers of HBV. 7 The prevalence of HBsAg in healthy blood donors ranges from 2.7% to 9.8%. 6, 8 However several surveys of voluntary blood donors in the Kingdom of Saudi Arabia have shown marked regional variations in the prevalence of HBV. [9] [10] [11] [12] In the region of Tabuk, which occupies the northwestern part of Saudi Arabia, information on the epidemiology and prevalence of HBV infection among the different population groups is inadequate. Most of the previous studies in the region have been limited to children less than 12 years of age as part of national studies aiming at evaluating the efficacy of HBV vaccine.
This study was carried out to determine the prevalence of HBV markers among blood donors at a tertiary care hospital in Tabuk, northwestern Saudi Arabia.
Methods
Tabuk is located in the northwest of Saudi Arabia. Its population is approximately 700 000 people, and they are served by 10 hospitals including the 300-bed King Khalid tertiary care hospital. The screening of blood donors is performed mainly in the laboratory of the King Khalid hospital using centrally procured kits and uniform protocols. The results of HBV marker testing obtained during the screening of blood donors are registered and reported. This research included all screened healthy male Saudi voluntary blood donors at the blood bank of King Khalid hospital over the period June 1, 2005 to May 31, 2006. They were volunteers and mainly relatives and friends of patients. In Saudi Arabia, females rarely donate blood due to cultural issues. Only three nonSaudi females donated blood during the period of the study.
Non-Saudi male and female blood donors were excluded from the study as they are exposed to mandatory screening for blood-borne pathogens before coming to Saudi Arabia to work and prior to the granting and renewal of their residency permits in this country.
Subjects were tested for HBsAg, anti-HBc (anti-hepatitis B core antigen), and antibodies to HCV and HIV, in addition to venereal disease research laboratory (VDRL) and malaria as part of the routine screening for blood donation. From each subject, 5-10 ml of venous blood was obtained and serum was separated by centrifugation and then forwarded for testing. A commercially available enzyme immunoassay (EIA; Abbott Laboratories, Chicago, IL, USA) was used for the detection of HBsAg and anti-HBc. In addition, a questionnaire sheet was prepared and used for each study subject. This was used to collect personal information (name (optional), age, and sex), socioeconomic data (such as marital status, education, and occupation), history of exposure to risky procedures or behaviors, family history of HBV infection, and history of immunization against HBV in three doses. Education was categorized as higher education for university degree and lower education for no education, primary, middle, or high school level only. Doctors, engineers, teachers, lawyers, and accountants were considered professionals while those in other occupations included general laborers, military personnel, and students. Study subjects were divided into four groups regarding exposure to risky procedures or behaviors. Group 1 included subjects with a history of surgery, blood transfusion, or dental surgery. Group 2 included those exposed to traditional risk procedures such as cauterization, scarification, or tattooing. Group 3 included those exposed to high-risk sexual behavior such as unprotected sex, multiple sexual partners, anal sex, or sexually transmitted diseases. Group 4 included those involved in intravenous (IV) drug addiction, needle or sharps injuries. A history of immunization was considered 'yes' if the subject had received three doses of HB vaccine at 0, 1, and 6 months, while 'no' was set for lesser or no doses or unknown history. Data were obtained, tabulated, and statistically analyzed using EPI Info software (version 6.0, Centers for Disease Control and Prevention, Atlanta, GA, USA). Subjects with positive HBV markers were compared to those with negative HBV markers with regard to different risk factors. Odds ratios with 95% confidence intervals were calculated. A p-value of less than 0.05 was considered significant.
Results
A total of 3192 subjects were included in the study. The age range was 18-52 years, the median age was 27 years, and the mean age was 28.6 AE 6.7 years. The prevalence of HBsAg was found to be 3.0% and the prevalence of anti-HBc was found to be 18.7%. The distribution of blood donors according to age, marital status, education, occupation, exposure to risky procedures/behavior, family history of HBV infection, and history of HB immunization in relation to HBV markers is shown in Table 1 .
Regarding age, HBV markers were significantly higher in age groups 30-39 years and !40 years compared to the youngest age group (<20 years). The difference in HBV markers for the age group 20-29 years in comparison to the youngest age group (<20 years) was not significant. Of the married subjects, 25.1% showed HBV markers compared to 16.7% of the unmarried subjects ( p < 0.05). Of the lower educated subjects, 23.7% showed HBV markers compared to 16.9% of the higher educated ( p < 0.05). With regard to occupation, laborers, either skilled or not, showed the highest percentage of HBV markers (37.0%), followed by military personnel (23.5%). Both occupations showed significant association with HBV markers compared to professionals ( p < 0.05). The HBsAg marker was found in 11.6% of students and 5.1% of military blood donors. Regarding history of exposure to risky procedures or behaviors, all exposed groups showed no significant association with HBV markers ( p > 0.05). Of the subjects with a family history of HBV infection, 28.4% showed HBV positive markers compared to only 12.8% among those without ( p < 0.05). All study subjects previously immunized for HBV in three doses were negative for both HBsAg and anti-HBc. Of the non-immunized subjects, 3.2% were positive for HBsAg and 19.9% were positive for anti-HBc.
Discussion
The results of this study indicate that of the apparently healthy male Saudi voluntary blood donors in Tabuk region, HBV markers in blood donors, Tabuk, Saudi Arabia e Exposure to risky procedure/behavior: group 1 = history of surgery, blood transfusion, dental surgery; group 2 = cauterization, scarification, or tattooing; group 3 = high-risk sexual behavior, unprotected sex, multiple partners, anal sex, sexually transmitted diseases; group 4 = intravenous drugs, needle or sharp injuries.
3.0% were positive for HBsAg and 18.7% were positive for anti-HBc. This prevalence for HBsAg is lower than that reported in the eastern region (6.7%) and the southwestern region (5.4%), but higher than that reported from the central region (1.5%) of Saudi Arabia. 13, 14 This prevalence is also higher than that reported from Western countries (0.1-0.5%), but lower than that from the Far Eastern countries. 15, 16 The prevalence of HBsAg among blood donors has been found to be 3.8% in Syria, 9.8% in Yemen, 1.2% in Egypt, and 1.2-1.7% in India. [17] [18] [19] [20] The prevalence of HBsAg among non-vaccinated children in Tabuk was 12.7% in 1989 but eight years later (in 1997) there was a decline in this prevalence to 0.5% among vaccinated children. 21 Unfortunately there are no previous studies among blood donors in Tabuk to compare these results with.
The significant association of HBV markers with older ages could be due to the greater number of years of potential exposure, a lack of adult HB vaccination programs, and the lack of awareness of HBV infection in earlier decades. Young blood donors should be encouraged to donate blood to help ensure a long-term increase in the blood supply without jeopardizing safety. The differences between males and females could not be evaluated because all subjects were male.
An inverse relationship was observed between prevalence of HBV markers and the socioeconomic level of the studied population, and this result is consistent with other studies. 14, 22 The significant high frequency of HBV markers among married subjects could be due to their older age. Close to one fourth of the military subjects studied showed HBV positive markers. This finding could be explained by high-risk sexual behavior or the use of IV drugs, both of which are not uncommon in military areas. Further studies are necessary to investigate HBV infection in the military community, which represents the majority of the population living in this area.
This study showed no significant association between HBV markers and risky procedures/behaviors, which is not consistent with other studies. This could be explained by the effective infection control measures within healthcare facilities that prevent blood-borne pathogen transmission. Furthermore, traditional medical practices including scarifications, cauterizations, and tattooing have become infrequent as a result of a better utilization of free and accessible medical care facilities.
Family history of HBV infection was found to be significantly associated with HBV markers. This finding could be due to the close contact between family members especially children and adolescents. Shared toothbrushes, towels, and shaving items are common among families of a lower socioeconomic level. Al-Faleh et al. stated that HBV infection in Saudi Arabia is acquired mainly by horizontal transmission early in life. 21 Further studies are needed to investigate other means of HBV transmission within Saudi families.
HBV vaccination remains the cornerstone of any effective and efficient strategy to prevent HBV infection. This study showed that 100% of those with a history of immunization in three doses of HBV vaccine were found to be free from HBV markers. The finding of a very low percentage (only 6%) of HB immunization history among study subjects corresponds with the reality that HB vaccine was introduced to the expanded program of immunization (EPI) in the Kingdom of Saudi Arabia starting from October 1989 and blood donation is usually permitted only at age 18 years and older.
In summary, the prevalence of HBV markers among blood donors in the northwestern area of Saudi Arabia is higher compared to the central capital Riyadh area. Socioeconomic development, health education programs, and adult HB immunization programs targeting high-risk groups should be initiated. This is not a community-based study and the subjects cannot be representative of the entire population of the northwestern region of Saudi Arabia. Hence further community-based studies should be encouraged to better estimate the prevalence of HBV markers, including anti-HBs, HBeAg, and anti-HBe, among males and females.
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